Quarterly report · Q2
4109.TEDINET S100PL5J
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥19.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥37.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥2.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.3bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.6bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥58.6bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥56.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥58.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥13.9bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥45.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥42.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥42.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.8bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥16.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥595m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥94m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥242.27 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.83 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥422.97 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥145.45 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.79 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥194m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥77m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥116m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥9m |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.0bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥283m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥21.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥19.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥21.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥19.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥186m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥82m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥104m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥8m |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥15.6bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥125m |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.5bn |
| jpcrp040300-q2r_E00805-000Medicalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥69m |
| jpcrp040300-q2r_E00805-000Medicalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥69m |
| jpcrp040300-q2r_E00805-000Medicalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥332m |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥3.8bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥373m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥19.6bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥18.0bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.6bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥2.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 548
| Item | Context | Value | Unit |
|---|---|---|---|
| Other proceeds inv cf | Prior1YTDDuration | 1000000 | JPY |
| Other proceeds inv cf | CurrentYTDDuration | 22000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -1584000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -595000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -1029000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -767000000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | Prior1YTDDuration | 3601000000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | CurrentYTDDuration | － | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -806000000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -17000000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -21000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -323000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -455000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 2231000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -2051000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 173000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 600000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 3296000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 895000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 15245000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 15538000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 18542000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 16433000000 | JPY |
| Packing and transportation expenses sga | Prior1YTDDuration | 198000000 | JPY |
| Packing and transportation expenses sga | CurrentYTDDuration | 414000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 57000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 51000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 27000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 28000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 0 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -0 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 14000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 10000000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 4000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 1000000 | JPY |
| Provision for share based remuneration sga | Prior1YTDDuration | 13000000 | JPY |
| Provision for share based remuneration sga | CurrentYTDDuration | 14000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 359000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 233000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 15631000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 2326000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00805-000MedicalReportableSegmentsMember | 69000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 18027000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 82000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 18109000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 125000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 1476000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00805-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 1602000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |